TASLY(SH:600535) Xin Lang Cai Jing·2025-10-13 09:16Core Viewpoint - The company has received a drug registration certificate from the National Medical Products Administration for its product, Wengjing Decoction Granules, which is derived from a historical prescription and is aimed at treating specific gynecological conditions [1] Group 1: Product Information - Wengjing Decoction Granules is based on a prescription from the Song Dynasty and is included in the first batch of the National Administration of Traditional Chinese Medicine's list of classic ancient formulas [1] - The formulation consists of nine ingredients, including cinnamon, wine-soaked angelica, chuanxiong, vinegar-curcuma, peony root, and wine-soaked achyranthes [1] - The product is indicated for conditions such as menstrual irregularities and abdominal pain due to blood deficiency and stagnation [1] Group 2: Financial Investment - The company has invested a total of 10.7155 million RMB in the research and development of this product to date [1]